Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113187717> ?p ?o ?g. }
- W2113187717 endingPage "233" @default.
- W2113187717 startingPage "224" @default.
- W2113187717 abstract "While chemotherapy based on alkylating agents has been the standard treatment of chronic lymphocytic leukemia (CLL) for decades, purine analogues and their combinations have emerged as effective new therapies for previously untreated and pretreated patients. As single agents, fludarabine and cladribine are the most promising, showing higher remission rates compared to chlorambucil. For younger and physically fit patients, the combination of fludarabine and cyclophosphamide has shown benefit. Fludarabine plus epirubicin appears equally potent. The addition of monoclonal antibodies, such as rituximab and alemtuzumab, to purine analogues alone or in combination seems to be even more effective for chemotherapy-naive and pretreated CLL patients. Another promising agent in the armamentarium of therapies for CLL is bendamustine, which has properties of both an alkylating agent and a purine analogue. Clinical trials are ongoing with novel drugs that interfere with cell cycle regulation and signaling molecules in CLL, including flavopiridol, UCN-01, bryostatin 1, depsipeptide, and oblimersen. It remains to be seen whether these chemotherapeutic approaches offer real benefit for patients by prolonging survival with an improved quality of life." @default.
- W2113187717 created "2016-06-24" @default.
- W2113187717 creator A5021332351 @default.
- W2113187717 creator A5076077834 @default.
- W2113187717 creator A5088826331 @default.
- W2113187717 date "2004-07-01" @default.
- W2113187717 modified "2023-09-27" @default.
- W2113187717 title "Advances in chemotherapy for chronic lymphocytic leukemia" @default.
- W2113187717 cites W1494274243 @default.
- W2113187717 cites W1592975144 @default.
- W2113187717 cites W1594668159 @default.
- W2113187717 cites W1635565950 @default.
- W2113187717 cites W168625184 @default.
- W2113187717 cites W1710792668 @default.
- W2113187717 cites W1879795494 @default.
- W2113187717 cites W1894269341 @default.
- W2113187717 cites W1930759119 @default.
- W2113187717 cites W1984455679 @default.
- W2113187717 cites W1987561205 @default.
- W2113187717 cites W1991529551 @default.
- W2113187717 cites W1997101371 @default.
- W2113187717 cites W1999317790 @default.
- W2113187717 cites W2002395765 @default.
- W2113187717 cites W2004513962 @default.
- W2113187717 cites W2012670544 @default.
- W2113187717 cites W2014631400 @default.
- W2113187717 cites W2015120596 @default.
- W2113187717 cites W2021595472 @default.
- W2113187717 cites W2034476737 @default.
- W2113187717 cites W2042010784 @default.
- W2113187717 cites W2055127867 @default.
- W2113187717 cites W2061000716 @default.
- W2113187717 cites W2061748159 @default.
- W2113187717 cites W2070193300 @default.
- W2113187717 cites W2070610819 @default.
- W2113187717 cites W2072539551 @default.
- W2113187717 cites W2076770653 @default.
- W2113187717 cites W2083583099 @default.
- W2113187717 cites W2084899812 @default.
- W2113187717 cites W2087507015 @default.
- W2113187717 cites W2102235447 @default.
- W2113187717 cites W2107433970 @default.
- W2113187717 cites W2108560452 @default.
- W2113187717 cites W2109876365 @default.
- W2113187717 cites W2116248495 @default.
- W2113187717 cites W2123528154 @default.
- W2113187717 cites W2128644586 @default.
- W2113187717 cites W2129285584 @default.
- W2113187717 cites W2129869923 @default.
- W2113187717 cites W2133942008 @default.
- W2113187717 cites W2134538858 @default.
- W2113187717 cites W2137804513 @default.
- W2113187717 cites W2138543899 @default.
- W2113187717 cites W2142983050 @default.
- W2113187717 cites W2143821597 @default.
- W2113187717 cites W2150439521 @default.
- W2113187717 cites W2151250120 @default.
- W2113187717 cites W2152025286 @default.
- W2113187717 cites W2152184958 @default.
- W2113187717 cites W2161926682 @default.
- W2113187717 cites W2169884427 @default.
- W2113187717 cites W2176099867 @default.
- W2113187717 cites W2226417367 @default.
- W2113187717 cites W2271724340 @default.
- W2113187717 cites W2292102235 @default.
- W2113187717 cites W2326175431 @default.
- W2113187717 cites W2327708208 @default.
- W2113187717 cites W2339496993 @default.
- W2113187717 cites W2342926585 @default.
- W2113187717 cites W2396454380 @default.
- W2113187717 cites W2409741390 @default.
- W2113187717 cites W2466931351 @default.
- W2113187717 cites W2468288889 @default.
- W2113187717 cites W2571460904 @default.
- W2113187717 cites W286443710 @default.
- W2113187717 cites W61258569 @default.
- W2113187717 cites W65919465 @default.
- W2113187717 cites W2599647695 @default.
- W2113187717 doi "https://doi.org/10.1053/j.seminhematol.2004.05.004" @default.
- W2113187717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15269882" @default.
- W2113187717 hasPublicationYear "2004" @default.
- W2113187717 type Work @default.
- W2113187717 sameAs 2113187717 @default.
- W2113187717 citedByCount "19" @default.
- W2113187717 countsByYear W21131877172013 @default.
- W2113187717 crossrefType "journal-article" @default.
- W2113187717 hasAuthorship W2113187717A5021332351 @default.
- W2113187717 hasAuthorship W2113187717A5076077834 @default.
- W2113187717 hasAuthorship W2113187717A5088826331 @default.
- W2113187717 hasConcept C109246011 @default.
- W2113187717 hasConcept C126322002 @default.
- W2113187717 hasConcept C143998085 @default.
- W2113187717 hasConcept C181199279 @default.
- W2113187717 hasConcept C185592680 @default.
- W2113187717 hasConcept C2775952470 @default.
- W2113187717 hasConcept C2776476023 @default.
- W2113187717 hasConcept C2776694085 @default.
- W2113187717 hasConcept C2776755627 @default.